Evidence map›Paper›PMID 26587058›Full record

ArticleDiabetology & metabolic syndrome2015

A new compound heterozygosis for inactivating mutations in the glucokinase gene as cause of permanent neonatal diabetes mellitus (PNDM) in double-first cousins.

Adriana Mangue Esquiaveto-Aun, Maricilda Palandi De Mello, Maria Fernanda Vanti Macedo Paulino, Walter José Minicucci, Gil Guerra-Júnior, Sofia Helena Valente De Lemos-Marini

Open access · goldAbstract read
In one paragraph

Article in Diabetology & metabolic syndrome, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. A NovelGenes · 2022
    Article
  3. Variable presentations ofBMJ case reports · 2022
    Article
  4. Review
  5. Monogenic diabetes: a gateway to precision medicine in diabetes.The Journal of clinical investigation · 2021
    Review
  6. Genetic mutations associated with neonatal diabetes mellitus in Omani patients.Journal of pediatric endocrinology & metabolism : JPEM · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Adriana Mangue Esquiaveto-AunDepartment of Pediatrics, School of Medical Sciences (FCM), State University of Campinas (UNICAMP), Campinas, SP Brazil ; Center of Molecular Biology and Genetic Engineering (CBMEG), UNICAMP, Campinas, Brazil ; Center for Investigation in Pediatrics (CIPED), FCM, UNICAMP, Campinas, Brazil.ORCID 0000-0003-0061-8217
Maricilda Palandi De MelloCenter of Molecular Biology and Genetic Engineering (CBMEG), UNICAMP, Campinas, Brazil.
Maria Fernanda Vanti Macedo PaulinoDepartment of Pediatrics, School of Medical Sciences (FCM), State University of Campinas (UNICAMP), Campinas, SP Brazil.
Walter José MinicucciDivision of Endocrinology, Department of Clinical Medicine, FCM, UNICAMP, Campinas, Brazil.
Gil Guerra-JúniorDepartment of Pediatrics, School of Medical Sciences (FCM), State University of Campinas (UNICAMP), Campinas, SP Brazil ; Center for Investigation in Pediatrics (CIPED), FCM, UNICAMP, Campinas, Brazil.
Sofia Helena Valente De Lemos-MariniDepartment of Pediatrics, School of Medical Sciences (FCM), State University of Campinas (UNICAMP), Campinas, SP Brazil ; Center for Investigation in Pediatrics (CIPED), FCM, UNICAMP, Campinas, Brazil.
Universidade Estadual de Campinas (UNICAMP) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPermanent neonatal diabetes mellitus (PNDM) is a rare disorder, characterized by uncontrolled hyperglycemia diagnosed during the first 6 months of life. In general, PNDM has a genetic origin and most frequently it results from heterozygous mutations in KCNJ11, INS and ABCC8 genes. Homozygous or compound heterozygous inactivating mutations in GCK gene as cause of PNDM are rare. In contrast, heterozygosis for GCK inactivating mutations is frequent and results in the maturity-onset diabetes of young (MODY), manifested by a mild fasting hyperglycemia usually detected later in life. Therefore, as an autosomal recessive disorder, GCK-PNDM should be considered in families with history of glucose intolerance or MODY in first relatives, especially when consanguinity is suspected.

resultsHere we describe two patients born from non-consanguineous parents within a family. They presented low birth weight with persistent hyperglycemia during the first month of life. Molecular analyses for KCNJ11, INS, ABCC8 did not show any mutation. GCK gene sequencing, however, revealed that both patients were compound heterozygous for two missense combined in a novel GCK-PNDM genotype. The p.Asn254His and p.Arg447Gly mutations had been inherited from their mothers and fathers, respectively, as their mothers are sisters and their fathers are brothers. Parents had been later diagnosed as having GCK-MODY.

conclusionsMutations' in silico analysis was carried out to elucidate the role of the amino acid changes on the enzyme structure. Both p.Asn254His and p.Arg447Gly mutations appeared to be quite damaging. This is the first report of GCK-PNDM in a Brazilian family.

Indexed as

GCKGlucokinaseMODYPermanent neonatal diabetes mellitusPNDM

Identifiers

PMID26587058
PMCPMC4652399
OpenAlexW2176534822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.